Search Results (428)

The rapid emergence of antimicrobial resistance has intensified the need for advanced therapeutic platforms capable of improving the efficacy, stability, and targeted delivery of antimicrobial agents. Electrospun nanofibers have emerged as highly promising materials for biomedical applications due to their large surface area, high porosity, tunable morphology, and ability to incorporate a broad range of bioactive compounds. This review provides a comprehensive overview of the design, fabrication, and biomedical applications of electrospun bioactive nanofibers functionalized with antimicrobial drugs. It presents the main nanofiber fabrication techniques, with particular emphasis on electrospinning and the influence of solution, process, and environmental parameters on fiber morphology and drug-loading efficiency. Natural, synthetic, and hybrid polymer systems commonly employed in electrospun antimicrobial nanofibers are analyzed in relation to their physicochemical properties, biocompatibility, and therapeutic performance. In addition, the review highlights different drug incorporation strategies, including encapsulation, immobilization, and surface coating, as well as the mechanisms of action of antimicrobial agents. Recent advances in nanotechnology-based antimicrobial systems and their role in overcoming analytical, biopharmaceutical, and drug-delivery limitations are also examined. Furthermore, the review addresses current challenges related to scalability, reproducibility, stability, and clinical translation of electrospun nanofibers. Finally, future perspectives focusing on multifunctional, stimuli-responsive, and personalized antimicrobial nanofiber systems are discussed as promising directions for combating bacterial infections and reducing the global burden of antimicrobial resistance. Full article

Surface engineering strongly influences the performance, reliability, and safety of medical and biomedical devices, yet failures often originate at interfaces rather than in bulk materials alone. This review addresses the fragmented evidence base linking coating selection, interphase design, qualification testing, advanced characterization, and data-driven durability analysis. The objective is to provide an integrative, failure-mode-based framework for implants, reusable instruments, inhalation systems, diagnostics, wearables, and implantable electronics. A narrative synthesis of the peer-reviewed literature in coatings, biomaterials, electrochemistry, reliability, standards, and materials informatics was conducted, with qualitative tables used only when protocols were too heterogeneous for numerical pooling. The review compares physical vapor deposition (PVD), chemical and plasma-enhanced chemical vapor deposition (CVD/PECVD), atomic layer deposition (ALD), sol–gel/organically modified silica (ORMOSIL) hybrids, plasma polymers, parylene, bioactive or antimicrobial surfaces, and electronic encapsulation strategies. The main finding is that no universally superior coating exists; reliable performance depends on matching architecture and characterization to the dominant failure pathway, substrate compliance, geometry, sterilization or physiologic exposure, and the standards-constrained endpoint. The review further shows how electrochemical diagnostics, interfacial mechanics, multiphysics models, survival/reliability statistics, and carefully governed AI workflows can be combined to support service-life prediction and decision-oriented qualification. Full article

Cutaneous infections and chronic inflammatory wounds remain difficult to treat because antimicrobial resistance, polymicrobial biofilms, excessive protease activity, oxidative stress, and impaired barrier repair collectively reduce the effectiveness of conventional topical therapies. Plant-derived antimicrobial peptides (AMPs) and peptide-associated bioactives offer antimicrobial, antibiofilm, immunomodulatory, and tissue reparative potential; however, their clinical translation is limited by proteolytic instability, poor stratum corneum penetration, short cutaneous residence time, formulation variability, cytotoxicity risks and limited human evidence. The key research gap is the lack of an integrated translational framework linking plant-derived peptide bioactivity with polymer engineering, advanced delivery systems, skin microenvironment biology, manufacturability, and regulatory feasibility. This review aims to critically evaluate the design principles, therapeutic mechanisms, delivery platforms, and translational barriers of plant-based peptide–polymer therapeutics for cutaneous infection and inflammation. We summarize major classes of plant-derived antimicrobial peptides, including defensins, cyclotides, thionins, hevein-like peptides, snakins, lipid transfer proteins, and knottin-type scaffolds, and examine engineering strategies such as self-assembly, aromatic N-capping, PEGylation, lipidation, dendritic architectures, and stimuli-responsive conjugation. We further discuss topical matrices, nanocarriers, liposomes, electrospun fibers, and surface-tethered biomaterials as delivery platforms for improving peptide stability, local retention, and controlled release. Finally, we identify key translational bottlenecks, including selectivity, toxicity, scalability, batch reproducibility, regulatory classification, and insufficient clinical validation. Mechanism-driven peptide optimization, quality-by-design manufacturing, standardized preclinical models, and controlled clinical trials will be essential for advancing these systems toward safe and effective dermatological therapies. Full article

Background/Objectives: Bone infection remains a severe clinical challenge characterized by recurrence, antimicrobial resistance, and high morbidity, driving the search for new therapeutic strategies. Despite advances in developing biomaterials with suitable biocompatibility, biodegradability, and structural properties, the lack of effective antibacterial activity continues to significantly limit the treatment of bone defects. To overcome this issue, we investigated the incorporation of silver-based nanostructures into calcium polyphosphate/alginate (CPP/Alg) matrices as an antibacterial reinforcement strategy for bone-related applications. Methods: Silver nanoparticles (AgNPs) were synthesized in aqueous medium via NaBH₄-mediated chemical reduction, using either alginate (Alg) or sodium polyphosphate (PP) as stabilizing agents, enabling a comparative evaluation of biocompatible polymer- and polyphosphate-stabilized systems. Subsequently, AgNPs were incorporated into calcium polyphosphate/alginate (CPP/Alg) matrices to obtain Ag-containing composites. Results: The AgNPs exhibited spherical morphology, Zeta potential values ranging from −38.7 ± 0.2 to −23 ± 0.3 mV, and hydrodynamic diameters between 25.2 ± 0.2 and 143 ± 5 nm. Structural characterization of the biocomposites by X-ray diffraction confirmed hydroxyapatite as the major crystalline phase, while Raman spectroscopy revealed vibrational bands corresponding to both the inorganic and polymeric components. SEM revealed a dense, rough surface, and ICP-OES analysis confirmed the presence of Ag. Antibacterial activity assays demonstrated effective growth inhibition of Staphylococcus aureus and Staphylococcus epidermidis, with inhibition halos growing with increasing composite dosage. Notably, antibacterial activity was achieved at relatively low Ag contents, underscoring the efficiency of these biocomposites. Conclusions: These findings confirm the effective incorporation of AgNPs into the CPP/Alg matrix and support the classification of composites as promising antibacterial biomaterials for bone regeneration applications. Full article

Background/Objectives: BRI is a synthetic arylamide polymer designed to mimic the electrostatic and amphiphilic features of defensin-type antimicrobial peptides (AMPs), although its molecular organization and activity have not been experimentally validated. This study presents the first integrated computational and experimental characterization of BRI to define the physicochemical basis of its AMP-like behavior and membrane interactions. Methods: Molecular modelling was used to evaluate the structural and electrostatic properties of BRI. Model lipid membranes were used to study membrane interactions. Fluorescence spectroscopy, electrochemical measurements, and ζ-potential analyses were performed to characterize membrane insertion, aggregation, ionic conductance, and membrane resistance. Microbiology assays evaluating synergy with azole were also assessed. Results: Molecular modelling showed that BRI is a flexible molecule with cationic and hydrophobic surfaces, a strong amphiphilic dipole, and a dominant +4 charge state, explaining its sensitivity to ionic strength and membrane interactions. BRI displayed two membrane-dependent mechanisms of action. In zwitterionic phospholipid membranes, BRI resembled canonical AMPs, showing membrane insertion, pore formation, and increased ionic conductance. In anionic ergosterol-containing membranes mimicking fungal cells, BRI exhibited sterol-dependent insertion, in-plane aggregation, and modulation of membrane resistance without pore formation. Fluorescence, electrochemical, and ζ-potential measurements supported BRI–BRI interactions at the membrane interface and sensitivity to lipid domain organization. BRI also synergized with azole antifungal drugs, suggesting a mechanistic role for ergosterol in its antifungal activity. Conclusions: These findings reveal a sterol- and domain-mediated mechanism for arylamide polymers and identify lipid organization as a key determinant of antifungal activity. The dependence of BRI activity on ergosterol content provides a mechanistic explanation for its synergy with azole antifungals and supports further investigation of BRI as a membrane-active antifungal agent. Full article

This study developed high-oxygen-barrier active bilayer packaging films by combining corona-treated low-density polyethylene (LDPE) with chitosan/glycerol (CS/Gl) and carvacrol@natural zeolite (CV@NZ) nanohybrid layers using industrially scalable processes. LDPE film was surface-activated via ambient-pressure corona treatment (0.75 s/cm² at 45 kV, 30 W) and assembled with solution-cast CS/Gl or CS/Gl/CV@NZ monolayers via hot-pressing (110 °C, 1 min). Corona treatment enabled robust interfacial adhesion, evidenced by statistical equivalence between monolayer and bilayer mechanical properties. Incorporation of 10 wt.% CV@NZ nanohybrid increased elastic modulus by 60% (to ≈2970 MPa) and tensile strength by 30% (to ≈50 MPa). The LDPE-CS/Gl film achieved a 64-fold reduction in oxygen permeability; CV@NZ incorporation maintained excellent barrier performance (22-fold reduction). Antioxidant potency increased 16-fold upon CV@NZ incorporation. The LDPE-CS/Gl/CV@NZ film demonstrated exceptional antibacterial activity (5.08–5.30 log reductions; >99.999% kill) against both Listeria monocytogenes and Escherichia coli—substantially exceeding additive effects—confirming synergistic action between chitosan and carvacrol. In fresh minced pork preservation (8 days, 4 °C), the active film achieved a 1.73 log reduction in Total Viable Count (98.2% inhibition) and extended microbiological shelf life from 6 to beyond 8 days (33% increase). The bilayer configuration utilizes only 40% of the total thickness as biopolymer, aligning with circular economy principles. Unlike conventional high-barrier films (e.g., PA/PE) which require complex compatibilization for recycling, the water-soluble chitosan layer in this bilayer design can be readily separated from the LDPE backbone, enabling recovery of a pure polymer stream. This work demonstrates a feasible pathway for developing next-generation active packaging that combines a high oxygen barrier, potent antioxidant activity, and exceptional antimicrobial efficacy through industrially scalable manufacturing. Full article

Carbon dots (CDs), including carbon quantum dots (CQDs), are ultra-small carbon-based nanomaterials, typically below 10 nm, with tunable photoluminescence, high aqueous dispersibility, favorable biocompatibility, low toxicity, and abundant surface functional groups. These properties make CDs promising multifunctional platforms for nanomedicine, particularly in bioimaging, biosensing, targeted drug/gene delivery, photodynamic therapy (PDT), photothermal therapy (PTT), antimicrobial treatment, and theranostic applications. This review critically examines recent advances in CD fabrication, including top-down, bottom-up, green biomass-derived, microwave-assisted, hydrothermal, and emerging hybrid strategies, with emphasis on how precursor selection, heteroatom doping, surface passivation, and polymer/ligand functionalization regulate optical performance, biological interaction, and therapeutic efficiency. The review discusses structural classification, including CQDs, graphene quantum dots (GQDs), carbon nanodots, and carbonized polymer dots (CPDs), together with major characterization approaches such as ultraviolet–visible (UV–Vis) spectroscopy, Fourier-transform infrared (FTIR) spectroscopy, X-ray diffraction (XRD), X-ray photoelectron spectroscopy (XPS), Raman spectroscopy, and high-resolution transmission electron microscopy (HRTEM). Particular attention is given to red/near-infrared (NIR) emission, renal clearance, drug-loading behavior, reactive oxygen species (ROS) generation, toxicity mechanisms, biodistribution, and long-term biosafety. This review also highlights key translational barriers, including batch-to-batch variability, limited standardization, scalable manufacturing, regulatory uncertainty, and incomplete pharmacokinetic evaluation. It considers artificial intelligence (AI) and machine learning (ML) as emerging tools for reproducible CD design. CDs represent versatile and clinically promising nanoplatforms, but their translation requires standardized synthesis, rigorous safety assessment, and application-specific regulatory validation. Full article

Chronic wounds, diabetic foot ulcers, venous leg ulcers, and pressure injuries affect millions of patients worldwide and cost healthcare systems in the order of $150 billion annually, yet treatment options have changed less than the scale of the problem would suggest. Biofilm formation, documented in up to 78% of chronic wounds, is a central cause: bacteria embedded in extracellular polymeric matrices tolerate antimicrobial concentrations up to 1000-fold higher than planktonic cells and sustain a chronic inflammatory state that actively prevents tissue repair. Hydrogels, crosslinked polymer networks with high water content and tunable physicochemical properties, have been widely studied as platforms for addressing these challenges, though the distance between laboratory results and clinical practice remains considerable. While recent reviews have summarized hydrogel materials or antimicrobial strategies in isolation, this review takes a different approach: we treat infection, biofilm persistence, and impaired regeneration as interconnected processes that must be addressed simultaneously, and we examine biofilm management as a distinct therapeutic target rather than merely a subset of antimicrobial delivery. We analyze hydrogel-based wound care across three integrated domains: design principles (natural, synthetic, and hybrid polymer systems; crosslinking strategies; and stimuli-responsive architectures), antimicrobial delivery (silver, antibiotics, antimicrobial peptides, natural agents, and controlled-release systems), and biofilm management (nanoparticle-mediated disruption, enzymatic EPS degradation, photodynamic approaches, quorum-sensing inhibition, and anti-adhesive surface engineering). For each area, we critically evaluate what the preclinical evidence supports, where it falls short, and what would be needed to bridge the gap to clinical application. Translation remains uneven. Among the many FDA- and EMA-cleared hydrogel dressings currently in clinical use, most are simple moisture-retaining or silver-containing formulations, while the multifunctional systems that dominate the research literature are at earlier stages of development. We discuss the main translational priorities, including more predictive preclinical models, long-term nanomaterial safety, harmonized outcome reporting, manufacturing scalability, and health economic evidence, as areas where further work can meaningfully accelerate clinical adoption. Full article

Due to biodegradability, functionalization, and sustained release, polymer-based films are widely used in different industries. This study explores a bioactive emulsion-based film obtained using high-methoxy pectin (HMP), Origanum onites L. essential oil, and a hydroalcoholic extract of Thymus vulgaris L., prepared using various emulsion recipes. The emulsions obtained were applied to cellulose supports intended for topical applications. Bioactive textiles were analyzed using SEM-EDS elemental mapping, ATR FT-IR spectroscopy, biocompatibility assessment, antimicrobial activity assays, and analysis of comfort indices. SEM images of textile supports treated with bioactive emulsions confirmed the creation of a film surface and that the homogeneity of the film increases with increasing amount of glycerin, which acts as a plasticizer. Infrared spectra combined with their second derivatives and PCA indicate the presence of oregano essential oil, thyme extract, and pectin on the surface of the cotton. The biocompatibility evaluation of functionalized cotton supports revealed minimal cytotoxic effects on HaCaT human keratinocytes after 24 h of exposure. The results of the analyses showed that bioactive textile supports also exhibit antimicrobial activity. Therefore, the active emulsions with pectin, oregano essential oil, and hydroalcoholic extract of thyme provide biocompatible and antimicrobial active films by applying on cellulosic supports. Full article

Background: Sulfated chitosan (ChS) is a chemically modified polysaccharide derived from chitin that mimics heparan sulfate (HS) structures and has emerged as a promising antimicrobial biomaterial. Piscirickettsia salmonis, the etiological agent of Salmonid Rickettsial Septicemia (SRS), represents the main driver of antibiotic use in Chilean aquaculture. Objective: In this study, the in vitro antibacterial activity of ChS against P. salmonis was evaluated. Methods: Elemental characterization by SEM-EDS and FTIR analysis confirmed successful sulfation of the polymer, with a degree of sulfation ranging from 0.92 to 0.95. Additionally, X-ray diffraction (XRD) analysis revealed a reduction in polymer crystallinity, indicating a transition toward a more amorphous structure associated with increased molecular flexibility and functional group accessibility. Results: Antibacterial assays revealed a minimum inhibitory concentration (MIC) of 1500 µg/mL and a minimum bactericidal concentration (MBC ≥ 1500 µg/mL). LIVE/DEAD™ fluorescence imaging showed the formation of bacterial aggregates with increasing size, frequency, and red fluorescence compared to controls over the exposure to ChS, indicating progressive membrane damage. This was supported by a reduction (p < 0.05) in the Green/Red fluorescence ratio of 37–46% between 5 h and 96 h of exposure, corresponding to alteration of the cell membrane. Scanning electron microscopy revealed pronounced morphological alterations by ChS, including surface disruption and loss of cellular integrity. This was more severe compared to commercial chitosan (ChC). Also, ChS reduced (p < 0.05) biofilm formation (>50% at day 6 and 34.8% at day 8). Conclusions: These results demonstrated that ChS disrupts the cell membrane and reduces biofilm formation in P. salmonis, thereby affecting viability. This is the first report of the antibacterial effect of ChS, an HS analogue, against P. salmonis. Full article

Chloramphenicol is a broad-spectrum antimicrobial agent whose use in food-producing animals is prohibited in many countries due to its association with severe adverse effects, including idiosyncratic aplastic anemia and genotoxicity. Despite these restrictions, chloramphenicol residues continue to be detected in food products, environmental compartments, and biological matrices, highlighting the need for reliable and sensitive analytical monitoring. This review provides a comprehensive overview of current analytical strategies for the detection of drugs in food and environmental samples, covering screening and confirmatory techniques, sample preparation approaches, and regulatory aspects. Rapid screening methods, such as enzyme-linked immunosorbent assays (ELISAs), lateral flow immunoassays (LFIAs), and biosensors based on antibodies, aptamers, and molecularly imprinted polymers, enable fast and cost-effective preliminary detection. Recent advances in nanomaterials and signal amplification strategies, including fluorescent reporters and surface-enhanced Raman scattering (SERS), have significantly improved sensitivity and assay performance. However, confirmatory methods based on liquid chromatography coupled with tandem mass spectrometry (LC–MS/MS) remain the reference standard due to their superior selectivity, sensitivity, and quantitative reliability. Attention is given to sample preparation workflows, including QuEChERS-based protocols and microextraction techniques, which enable efficient analysis of complex matrices. Finally, current regulatory frameworks and analytical challenges related to zero-tolerance policies are discussed, emphasizing the importance of robust and validated analytical methods for effective monitoring and food safety assurance. Full article

Stone heritage deteriorates through physical, chemical, and biological processes driven by water, climate, and microbial colonization. Multifunctional polymeric coatings combining hydrophobic and antimicrobial moieties have emerged as a promising conservation strategy, yet a substantial gap remains between laboratory innovation and real-world performance. This review critically examines advances from 2021 to 2026, covering wetting theory, antimicrobial mechanisms, and material architectures, including molecularly integrated systems, Sol–Gel hybrids, nanocomposites, and layered systems. Long-term studies on the Aurelian Walls in Rome and stone in Reims show that biocidal efficacy typically declines within one to two years despite the chemical persistence of the coatings. In parallel, hydrophobic performance often deteriorates over time due to UV exposure, particulate deposition, and surface chemical changes, leading to increased wettability and reduced protective efficiency. Substrate porosity governs durability and visual compatibility (ΔE* < 5 threshold), while treatments can reshape microbial communities, favoring stress-tolerant meristematic fungi. Regulatory pressure on fluorinated compounds drives the development of more sustainable alternatives. Emerging directions include stimuli-responsive systems, self-healing materials, slippery interfaces, and precision polymer architectures. However, future progress will depend on tailoring formulations to major lithotypes, improving compatibility with porous substrates, and validating performance through standardized accelerated aging and multi-year field trials. Bridging laboratory design with environmental exposure data and conservation practice will be essential for achieving durable and culturally acceptable protection strategies. Full article

Hydrophilic colloids are ideal materials for preparing edible films; however, their intrinsic hydrophilicity leads to poor hydrophobicity in the resulting films. Emulsion-based films can significantly improve the hydrophobicity of films made from hydrophilic colloids, but this approach tends to disrupt intermolecular interactions within the film matrix. Phenolic compounds can compensate for this drawback by promoting crosslinking among film-forming polymers. In this study, hemp seed protein was used as the film-forming matrix, and rose essential oil was incorporated to prepare emulsion-based films. Different amounts of propolis flavonoids were added to investigate their effects on the physicochemical properties of the films. The results show that the addition of propolis flavonoids significantly reduced film whiteness (9%–45%), thickness (6%–37%), light transmittance (9%–60%), water vapor transmission rate (34%–65%), and peroxide value (25%–76%) of oil, while increasing tensile strength (15%–149%), elongation at break (24%–95%), Young’s modulus (26%–140%), surface hydrophobicity, thermal stability, and antioxidant and antimicrobial activities. Furthermore, pork wrapped with flavonoid-containing films exhibited inhibition of microbial growth, lipid oxidation, protein degradation, and maintained firmness. Therefore, propolis flavonoids represent a potential active ingredient for improving the physicochemical properties and preservative performance of emulsion-based films. Full article

Antimicrobial resistance (AMR) represents one of the major threats to global health, driven by the indiscriminate use of antibiotics and decline in the development of new therapeutic agents. In this context, essential oils (EOs) have emerged as innovative natural alternatives due to their broad-spectrum antimicrobial activity and low potential to induce bacterial resistance. However, their clinical application is limited by their volatility, low chemical stability, and rapid degradation. The incorporation of EOs into electrospun natural polymer fibers has emerged as an effective strategy to overcome these limitations, improving their stability, enabling controlled release, and enhancing their antimicrobial efficiency. This review focuses on the use of electrospun natural polymers for biomedical applications, highlighting their biocompatibility, biodegradability, and ability to mimic the extracellular matrix, thereby promoting cell interaction. Additionally, their high surface area and porous structure facilitate efficient encapsulation and controlled release of bioactive compounds. Recent advances in the development of these systems against clinically relevant multidrug-resistant pathogens are analyzed, along with the antimicrobial mechanisms of EOs. Finally, the factors influencing encapsulation and release efficiency, as well as the main challenges and future perspectives for clinical translation, are discussed. Full article

Polymer films and coatings play an increasingly critical role in extending material functionality across industrial, biomedical, and environmental applications. Recent advances in surface engineering have enabled precise control of interfacial properties, leading to enhanced durability, cleanliness, and protection. This review summarizes state-of-the-art strategies for modifying polymer surfaces, with an emphasis on plasma-based surface modification and plasma-induced polymerization as versatile, solvent-free methods for tailoring wettability, chemical functionality, and adhesion. Furthermore, it examines emerging classes of self-cleaning and self-sterilizing coatings that leverage photocatalytic, hydrophobic, or antimicrobial mechanisms to mitigate contamination, biofouling, and pathogen transmission. Additionally, developments in high-performance barrier films designed to protect food products and electronic devices through improved resistance to gases, moisture, and chemical agents are highlighted. By integrating insights from materials chemistry, surface physics, and nanostructured coating design, this review provides a comprehensive overview of current achievements and future directions in functional polymer films and coatings aimed at anti-pollution, antibacterial, and anti-corrosion performance. Full article